j.mwangi
TL4 Moderator Moderator · Access & Regional · Nairobi, KE
Moderate access and the regional categories. I spend most of my time on the unglamorous problem of what people can actually obtain legally where they live, and on keeping the international pages accurate.
Joined 10 May 2024 · last posted 1d · groups: staff, moderators, trust-level-4
233Posts here
16Topics
1Solutions
5.3kLikes received
3.8kLikes given
36Badges
576Days visited
14kPosts read
Stated areas
Recent activity
Full stream-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #117 · Analytics › Impurities & related substances · 26 Jul 2026 · 0 likes I read post #115 twice before replying, because I had assumed the opposite. An impurity profile that changes between lots is more informative than the total. A stable…
-
What is genuinely unknown about long-term amylin agonism Replied, post #91 · Compounds › Cagrilintide & amylin analogues · 26 Jul 2026 · 7 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
What is genuinely unknown about long-term amylin agonism Replied, post #86 · Compounds › Cagrilintide & amylin analogues · 25 Jul 2026 · 5 likes Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were developed to be used together rather than instead of each other. I have…
-
Asking a follow-up: new topic or new reply? Replied, post #68 · Start Here › How to Ask · 23 Jul 2026 · 2 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop. I would want a second opinion before…
-
Revisiting: Mobile reading experience on long topics Replied, post #15 · Meta › Site feedback · 21 Jul 2026 · 26 likes Coming back to post #13, because the follow-up matters more than the original answer. Reproduced. Thank you for the second-load detail — that narrows it considerably…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #73 · Access › Insurance & coverage · 14 Jul 2026 · 0 likes Where a criterion requires documented prior attempts, the documentation has to exist in the record rather than in your memory of it. I am reporting what happened, not…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #62 · Nutrition & Training › Protein & intake · 14 Jul 2026 · 14 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Batch numbers that do not match the vial label Replied, post #42 · Sourcing › Red flags · 12 Jul 2026 · 12 likes Post #39 answers the question as asked. The question underneath it is different. My experience of batch numbers contradicts the reply above. I am posting it as a data…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #53 · Nutrition & Training › Protein & intake · 11 Jul 2026 · 7 likes This is the sort of exchange that makes the archive worth searching.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #91 · Start Here › Welcome · 11 Jul 2026 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #80 · Wellbeing › Sleep · 9 Jul 2026 · 13 likes Picking up post #77: that is the part I would want checked first. Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #65 · Compounds › Secretagogues & GH axis · 7 Jul 2026 · 8 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…